An open clinical trial on teh efficacy of H-AL pollens (Grass mixture I) administered orally and sublingually in patients with indicated allergen immunotherapy (AIT) with Type I allergy mediated by IgE antibodies (pollens allergy), enrolled in the clinical trial according to the protocol MS01092001 -
- Conditions
- Type I allergy to pollens mediated by IgE antibodies
- Registration Number
- EUCTR2004-001521-19-CZ
- Lead Sponsor
- SEVAPHARMA a.s.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
1.Voluntarily signed informed consent after a complete infromation of teh subject.
2.Subject, who properly finished the clinical trial according to the protocol MS01092001.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1.Subject, who did not properly finish the clinical trial according to the protocol MS01092001.
2.Pregnant women and women in lactation.
3.Subject unable of cooperation or irresponsible.
4.Drugs or alcohol addict.
5.Not willing to sign the informed consent.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method